Ashraf Aleyasin1, Elham Saffarieh2, Hassan Torkamandi3, Somayeh Hanafi3, Fariborz Sadeghi3, Atossa Mahdavi1, Fatemeh Bahmaei1, Mohammadreza Javadi4. 1. Obstetrics and Gynecology Department, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2. Abnormal uterine Bleeding Research Center, Semnan University of Medical Sciences, Semnan, Iran. 3. Pharmaceutical Care Department, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. 4. Clinical Pharmacy Department, College of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran ; Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran.
Abstract
PURPOSE: Hyperemesis gravidarum is the third leading cause of hospitalization during pregnancy. 5-HT3-receptor antagonists are the most effective against chemotherapy-induced nausea and vomiting and radiation. This randomized study aimed to compare and evaluate the efficacies of granisetron and promethazine for controlling nausea and vomiting of pregnancy. METHODS: The included patients were administered (oral and intravenous) granisetron and promethazine randomly. The patients were evaluated for nausea and vomiting by a senior gynecology resident blinded to designated drugs. RESULTS: This study revealed that granisetron significantly decreased nausea and vomiting in pregnant women (p < 0.05). Greater patient satisfaction and lesser adverse drug reactions in women receiving granisetron observed in this study suggest that it can be introduced as a more effective and safer drug in comparison with promethazine. CONCLUSIONS: Considering the prevalence of nausea and vomiting of pregnancy and hyperemesis gravidarum, we can state that it is a health-related problem with economic, social and psychological dimensions. All efforts especially simple outpatient strategies to reduce its severity will help the pregnant woman continue her pregnancy with more satisfaction.
RCT Entities:
PURPOSE:Hyperemesis gravidarum is the third leading cause of hospitalization during pregnancy. 5-HT3-receptor antagonists are the most effective against chemotherapy-induced nausea and vomiting and radiation. This randomized study aimed to compare and evaluate the efficacies of granisetron and promethazine for controlling nausea and vomiting of pregnancy. METHODS: The included patients were administered (oral and intravenous) granisetron and promethazine randomly. The patients were evaluated for nausea and vomiting by a senior gynecology resident blinded to designated drugs. RESULTS: This study revealed that granisetron significantly decreased nausea and vomiting in pregnant women (p < 0.05). Greater patient satisfaction and lesser adverse drug reactions in women receiving granisetron observed in this study suggest that it can be introduced as a more effective and safer drug in comparison with promethazine. CONCLUSIONS: Considering the prevalence of nausea and vomiting of pregnancy and hyperemesis gravidarum, we can state that it is a health-related problem with economic, social and psychological dimensions. All efforts especially simple outpatient strategies to reduce its severity will help the pregnant woman continue her pregnancy with more satisfaction.
Authors: Tyler W Barrett; David M DiPersio; Cathy A Jenkins; Meg Jack; Nicole Streiff McCoin; Alan B Storrow; Lori M Singleton; Patricia Lee; Chuan Zhou; Corey M Slovis Journal: Am J Emerg Med Date: 2010-03-26 Impact factor: 2.469
Authors: Fergus P McCarthy; Ali S Khashan; Robyn A North; Rona Moss-Morris; Philip N Baker; Gus Dekker; Lucilla Poston; Louise C Kenny Journal: PLoS One Date: 2011-11-18 Impact factor: 3.240
Authors: Anh L Ngo; Vwaire Orhurhu; Ivan Urits; Edwin O Delfin; Medha Sharma; Mark R Jones; Omar Viswanath; Richard D Urman Journal: Saudi J Anaesth Date: 2019 Jul-Sep